National Wealth Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,274
| Closed | -$960K | – | 131 |
|
|
2024
Q1 | $960K | Buy |
5,274
+3,511
| +199% | +$639K | 0.75% | 35 |
|
|
2023
Q4 | $273K | Buy |
1,763
+53
| +3% | +$8.21K | 0.26% | 107 |
|
|
2023
Q3 | $255K | Sell |
1,710
-4
| -0.2% | -$596 | 0.28% | 107 |
|
|
2023
Q2 | $256K | Sell |
1,714
-9,575
| -85% | -$1.43M | 0.27% | 106 |
|
|
2023
Q1 | $1.66M | Buy |
11,289
+9,700
| +610% | +$1.43M | 1.9% | 10 |
|
|
2022
Q4 | $257K | Sell |
1,589
-2,497
| -61% | -$404K | 0.31% | 104 |
|
|
2022
Q3 | $548K | Buy |
4,086
+2,559
| +168% | +$343K | 0.71% | 32 |
|
|
2022
Q2 | $234K | Sell |
1,527
-538
| -26% | -$82.4K | 0.29% | 92 |
|
|
2022
Q1 | $335K | Buy |
2,065
+459
| +29% | +$74.4K | 0.32% | 73 |
|
|
2021
Q4 | $218K | Buy |
+1,606
| New | +$218K | 0.2% | 112 |
|